-+ 0.00%
-+ 0.00%
-+ 0.00%

Leads Biolabs Reports Promising Phase I/II Results for LBL-034 in Relapsed/Refractory Multiple Myeloma

Reuters·12/08/2025 02:00:47

Please log in to view news